Google
ENLV — ENLIVEX THERAPEUTICS LTD (Healthcare >> Biotechnology)
ENLV FAQ
What is ENLV's P/E ratio?
ENLIVEX THERAPEUTICS LTD (ENLV) currently trades at a P/E ratio of 0.03.
What is ENLV's ROE?
ENLIVEX THERAPEUTICS LTD reports a Return on Equity (ROE) of 63.85%.
What is ENLV's dividend yield?
ENLIVEX THERAPEUTICS LTD offers a dividend yield of 0.00%.
What is ENLV's Deepscope Quality Score?
Deepscope rates ENLV's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ENLV?
Deepscope's AI Timing Score for ENLV is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ENLV belong to?
ENLIVEX THERAPEUTICS LTD is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 0.69
Price
-0.02
(-3.02%)
Day Change
|
|
|---|
ENLV Chất lượng tổng thể của cố phiếu Khá ( Chất lượng = 62) và Thời điểm mua ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt lắm , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...
| Yếu tố Chất lượng |
|
54% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 74 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.69 |
| PBV / Sector |
0.02 / 4.71
GREAT
|
| Earning Per Share | 25.48 |
| PE / Sector |
0.03 / 17.58
GREAT
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
0.33 M
GREAT
|
| Average 1W Daily Value |
0.25 M
GREAT
|
| Yếu tố Kỹ thuật |
|
28% |
| Sức khỏe tài chính |
|
41% |
| Khả năng kiếm lợi nhuận |
|
37% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-10 09:43:05 |
| Symbol | ENLV |
| Name | ENLIVEX THERAPEUTICS LTD |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 241.05 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 33.38 / 8,889.42 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 14 Einstein Street, Ness Ziona, Israel, 7403618
Phone: 972 2 620 8072
Website: https://www.enlivex.com
Sector: Healthcare >> Biotechnology
Description: Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
